Today’s price, $390, sits below the range. 31.9% below the $572.68 the four methods put it at.
UNDERVALUEDThe real sections, opened with your free account.
The 4 methods put Humana’s fair value around $573 a share.
Is it growing? Over the last 3 years, Humana's sales have grown about 12% a year. In its latest quarter (Q3 '26), sales were about 26% higher than the same quarter a year earlier.
Does it make money? Yes. Of every dollar of sales, Humana keeps about 13 cents after making the product, 2 cents after running the business and 1 cents as profit after everything, tax included.
Latest report: July to September 2026 (quarter ended Sep 30, 2026), reported Nov 6, 2026 before the open.
Expectations are analysts’ averages as of Nov 5, 2026, before the report.
From the company's quarterly statements through Sep 30, 2026.
Humana revises its GAAP EPS guidance for the year ending December 31, 2026 (FY 2026) to 'at least $15.09' from 'at least $6.52', while raising its Adjusted EPS guidance to 'at least $9.50' from the previous guidance of 'at least $9.00'.
From the earnings release filed Nov 6, 2026.
The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how HUM moved after its last eight reports.
See HUM’s full earnings read, free →